COMPOSITION POUR LE DIAGNOSTIC ET LE TRAITEMENT D'UNE MALADIE HEPATIQUE ALCOOLIQUE, UTILISANT UNE COMMUNAUTE BACTERIENNE INTESTINALE PRODUISANT UN CHANGEMENT D'ACIDES GRAS A CHAINE COURTE
The present invention relates to a bacterial strain capable of serving as a biomarker for alcoholic fatty liver and a pharmaceutical composition for preventing or treating alcoholic fatty liver, a food composition for preventing or alleviating alcoholic fatty liver, or a probiotics composition for preventing or alleviating alcoholic fatty liver, each composition comprising the bacterial strain as an effective ingredient.